Clinical significance of heparin in the residual pump oxygenator blood,reinfused postoperatively after cardiopulmonary bypass

Abstract

Postcardiopulmonary bypass (CPB) heparin levels and thrombin time were measured in 20 patients following routine open cardiac operations.

There was a statistically significant increase in heparin concentration and thrombin time ratio on completion of transfusion of the residual pump oxygenator blood. An hour after the end of the transfusion there was no statistically significant difference in the heparin concentration and thrombin time ratio compared to values before and immediately after transfusion.

We also observed a significant decrease in the chest drainage over a period of four hours which was unrelated to plasma heparin level. Measurements of thrombin time in the post bypass period closely follow plasma heparin levels. If postoperative bleeding arose it was due to inadequate surgical haemostasis or coagulation defect other than residual heparinization. Thus this confirms further that heparin is not the sole aetiological factor in postoperative bleeding post-CPB.

Get full access to this article

View all access options for this article.

References

Bull BS , Huse WM , Brauker FS , Korpman RA Heparin therapy during extracorporeal circulation II. The use of dose response curve to individualise the heparin and protamine dose. J Thorac Cardiovasc Surg 1975; 69: 685-89.

Bull BS , Korpman RA , Huse WM , Briggs BD Heparin therapy during extracorporeal circulation I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975; 69: 674-84.

Ponari O. , Corsi M. , Manotti C. , Pini M. , Portioli D. , Poti R. Predictive value of pre-operative in vitro and in vivo studies for correct individual heparinization in cardiac surgery. J Thorac Cardiovasc Surg 1979; 78: 87-94.

Kaul TK , Crow MJ , Raiah SM , Deverall D. , Watson DA Heparin administration during extracorporeal circulation. Heparin rebound and postoperative bleeding. J Thorac Cardiovasc Surg 1979; 78: 95-102.

Hattersley PG Activated clotting time of whole blood. JAMA 1966; 196: 150-54.

Mayer ED , Welsch M. , Tanzeem A. et al. Reduction of post-operative donor blood requirements by use of the cell separator. Scan J Thorac Cardiovasc Surg 1985; 19: 165-71.

Cipolle RJ , Sefert RD , Neilan BA , Zaske DE , Hans E. Heparin kinetics variables related to disposition and dosage. Clin Pharmacol Ther 1981; 29: 387-93.

Babka R. , Colby C. , El-Etr A. , Pifarre R. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass. J Thorac Cardiovasc Surg 1974; 73: 780-82.

Rothni NG , Kinmouth JB Bleeding after perfusion for open heart surgery. B Med J 1960;1: 73-78.

10.

Jobes DR , Schwartz AJ , Ellson NE , Andrews R. , Ruffini RA , Buffini JJ Monitoring heparin anticoagulation and its neutralisation. Ann Thorac Surg 1981; 31: 161-66.

11.

Lowary LR , Smith FA , Coyne E. , Dunham NW Comparative neutralisation of lung and mucosal derived heparin by protamine sulphate using in vitro and in vivo methods. J Pharm Sci 1971; 60: 638-40.

12.

Bartl K. , Dorsh E. , Ziegenhorn YJ Paper presented at the 23rd meeting of Deutsche Arbeitsgemeinschaft fur Blutgerinnungs fur chung. Heidelberg, West Germany, 1979.

13.

Esposito RA , Culliford AT , Colvin SB , Thomas SJ , Lackner H. , Spencer FC The role of the activated clotting time in heparin administration and neutralisation for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 85: 174-85.

14.

Cohen JA , Frederickson EL , Kaplan JA Plasma heparin activity and antagonism during CPB with hypothermia . Anesth Anal 1977; 56: 564-70.

15.

Gundry SR , Drongowski RA , Klein MD , Coran AG

Post-operative bleeding in cardiovascular surgery. Does heparin rebound really exist?

Am Surg 1989; 55: 162-65.

16.

Culliford AT , Gitel SN , Starr N. et al. Lack of correlation between the ACT and the plasma heparin level during CPB. Ann Surg 1981; 193: 105-11.

17.

Harker LA Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: 1446-47.

18.

Pardamani DS , Roy C. , Sen PR Heparin rebound. A clinical study in cases of open heart surgery under CPB. J Postgrad Med 1969; 16: 26-32.

19.

Keuiunen AH , Salmenpera MT , Heinonen J. , Rasi VP , Myllyla G. Heparin rebound: a comparative study of protamine chloride and protamine sulphate in patients undergoing coronary artery bypass surgery. J Cardiovasc Anaesth 1991;5: 221-26.

20.

Martin P. , Horkay F. , Gupta NK , Gefitekin C. , Walker DR Heparin rebound phenomenon - much ado about nothing? Blood Coagul Fibrinolysis 1992; 3: 187-91.